Valenzabio And Novelty Nobility Announce Exclusive License Agreement For Potential Best-In-Class Anti-C-Kit Monoclonal Antibody

Valenzabio, Inc., A Biopharmaceutical Company Developing Monoclonal Antibody (Mab) Therapeutics For Autoimmune And Inflammatory Indications, And Novelty Nobility Inc, A Biotechnology Company Specializing In The Design, Discovery, Optimization, And Early Stage Development Of Next Generation Antibodies, Today Announced An Exclusive Worldwide License Agreement For The Development And Commercialization Of Vb517, A Potentially Best-In-Class Anti-C-Kit Mab For Mast Cell-Driven Autoimmune Diseases. C-Kit Is A Receptor Tyrosine Kinase Critical To The Survival And Activation Of Mast Cells. Blocking C-Kit Has Been Shown To Reduce Mast Cell Degranulation And Induce Mast Cell Depletion In Clinical Studies. Vb517 Is A Fully Human Mab With Low-Picomolar Affinity For C-Kit And Has Demonstrated Potent Suppression Of Human Mast Cell Activation In Preclinical Models. Valenzabio Plans To Initiate Clinical Studies Of Vb517 In 2023.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!